Because of generous supporters, like you, nine new clinical and translational science research projects received funding this year. These projects are excellent examples of the high quality, exciting research taking place right here in Canada! We wouldn’t be able to support research like this without YOU.
2021-2022
RECIPIENTS:
Building a screenable human 3D neuromuscular junction model for neuromuscular disorders
Dr. Thomas Durcan
The Royal Institution for the Advancement of Learning/McGill University
Mitochondrial-targeted therapies to improve Duchenne muscular dystrophy outcomes
Dr. Christopher Perry
York University
Genome-wide DNA methylation profile in Duchenne muscular dystrophy
Dr. Craig Campbell
London Health Sciences Centre
(Lawson Health Research Institute)
Measuring balance in chronic inflammatory demyelinating polyneuropathy
Dr. Michael Berger
University of British Columbia
Endurance training as a novel therapeutic strategy for myotonic dystrophy type 1
Dr. Bernard Jasmin
University of Ottawa
QP-OPMD: Quantitative MRI imaging to assess progression in oculopharyngeal muscular dystrophy
Dr. Jodi Warman Chardon
Ottawa Hospital Research Institute
Exploring the impact of spinal bulbar muscular atrophy on persons self-identifying as Indigenous
Dr. Kerri Schellenberg
The University of Saskatchewan
The transition of TEENagers with spinal muscular atrophy to a multi-disciplinary adult program
Dr. Reshma Amin
The Hospital for Sick Children
Motor network connectivity in spinal muscular atrophy: new pathways for intervention
Dr. Maryam Oskoui
The Research Institute of the McGill University Health Centre
“I am so excited and honoured to receive a Neuromuscular Clinical and Research Grant. Because of this funding, we’re going to be able to look very carefully at how Oculopharyngeal Muscular Dystrophy (OPMD) progresses with muscle MRI. We will be looking at the percentage of how the dystrophy changes, which will allow us to get the population of OPMD patients ready for when there are new therapies coming out,” says Dr. Jodi Warman Chardon. “We will be able to use this imaging technique for many different NMDs, which will position us better in Canada to have more studies on OPMD and other neuromuscular disorders (NMD). We’re really excited about how this is going to change care, enhance our ability to assess patients and how it can be used for other therapies and trials in the future.”
GET IN TOUCH!
Visit muscle.ca/services-support/research/ to learn more about these and other research projects. If you have a specific research question, our dedicated Research Hotline is here to help! Call 1-800-567-2873 ext 1114 or email research@muscle.ca and our research team will provide you with accurate and timely answers.
